Marengo Therapeutics, Inc.

Ipsen and Marengo Therapeutics Announce Second Strategic Partnership

Ipsen and Marengo Therapeutics Inc, a clinical-stage biotech company, announced today the expansion of their ongoing oncology research partnership, to include TriStar, Marengo’s next-generation, precision T cell engager (TCE) technology.